Cargando…

The magnitude of depression in heart failure patients and its association with NYHA class

INTRODUCTION: Depression is commonly present among HF patients and is associated with adverse clinical outcomes. However, research regarding its association with New York Heart Association (NYHA) class is still scarce. OBJECTIVES: To evaluate the presence of depression symptoms in HF outpatients and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botto, J., Martins, S., Moreira, E., Cardoso, J. Silva, Fernandes, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470819/ http://dx.doi.org/10.1192/j.eurpsy.2021.918

Ejemplares similares

Anxiety in heart failure patients and its association with NYHA class
por: Costa, F., et al.
Publicado: (2021)

Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy
por: Briongos‐Figuero, Sem, et al.
Publicado: (2019)

Extracting Features from Poincaré Plots to Distinguish Congestive Heart Failure Patients According to NYHA Classes
por: D’Addio, Giovanni, et al.
Publicado: (2021)

Skeletal muscle molecular alterations precede whole-muscle dysfunction in NYHA Class II heart failure patients
por: Godard, Michael P, et al.
Publicado: (2012)

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
por: Athanasakis, Kostas, et al.
Publicado: (2016)

Circulating stem cell vary with NYHA stage in heart failure patients
por: Fortini, Cinzia, et al.
Publicado: (2011)

Remote monitoring of pulmonary artery pressures with CardioMEMS in patients with chronic heart failure and NYHA class III: first experiences in the Netherlands
por: Brugts, J. J., et al.
Publicado: (2017)

Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective
por: Ademi, Zanfina, et al.
Publicado: (2016)

Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
por: Wechsler, Maximilian, et al.
Publicado: (2022)

CRT-D Therapy in Patients with Decompensated NYHA Class-Four CHF
por: Zaeem, Faisal, et al.
Publicado: (2012)

Using the NYHA Classification as Forecasting Tool for Hospital Readmission and Mortality in Heart Failure Patients with COVID-19
por: Citu, Ioana Mihaela, et al.
Publicado: (2022)

Associations of mood symptoms with NYHA functional classes in angina pectoris patients: a cross-sectional study
por: Yin, Han, et al.
Publicado: (2019)

Study on the Differences between Traditional Chinese Medicine Syndromes in NYHA I–IV Classification of Chronic Heart Failure
por: Shi, Jun, et al.
Publicado: (2019)

Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
por: Cheng, Richard K., et al.
Publicado: (2020)

Diagnostic accuracy of plasma brain natriuretic peptide for evaluation of dyspnea NYHA-III and NYHA-IV in emergency department of tertiary care hospital
por: Saghir, Hina, et al.
Publicado: (2023)

A moderate 500-m treadmill walk for estimating peak oxygen uptake in men with NYHA class I-II heart failure and reduced left ventricular ejection fraction
por: Mazzoni, Gianni, et al.
Publicado: (2018)

Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm
por: Ferre-Vallverdu, Maria, et al.
Publicado: (2021)

Assessing right ventricular function in pulmonary hypertension patients and the correlation with the New York Heart Association (NYHA) classification
por: Shang, Xiaoke, et al.
Publicado: (2017)

Exercise Capacity and Cardiorespiratory Fitness in Children with Congenital Heart Diseases: A Proposal for an Adapted NYHA Classification
por: Neunhaeuserer, Daniel, et al.
Publicado: (2022)

Pulmonary perfusion and NYHA classification improve after cardiac resynchronization therapy
por: Al-Mashat, Mariam, et al.
Publicado: (2021)

Classificação da NYHA e as Variáveis do Teste de Exercício Cardiopulmonar em Pacientes com Insuficiência Cardíaca
por: Costa, Ricardo Vivacqua Cardoso
Publicado: (2022)

Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study
por: Shuvy, Mony, et al.
Publicado: (2023)

The soluble ST2 levels in patients with depression and comorbid heart failure
por: Sikora, A., et al.
Publicado: (2022)

Anxiety in heart failure patients and its association with socio-demographic and clinical characteristics: a cross-sectional study
por: Costa, Filipa M. D., et al.
Publicado: (2022)

Social connection and depression: an umbrella review of meta-analyses assessing the magnitude of risk and protection
por: Pettorruso, M., et al.
Publicado: (2023)

Assessing Right Ventricular Function in Patients with Hypertrophic Cardiomyopathy with Cardiac MRI: Correlation with the New York Heart Function Assessment (NYHA) Classification
por: Zhang, Shuai, et al.
Publicado: (2014)

Depressive symptoms and co-dependency in caregiver of patients with chronic heart failure
por: Yıldırım, A., et al.
Publicado: (2023)

Improvement of exercise tolerance in cardiopulmonary testing with sustained safety after regular training in outpatients with systolic heart failure (NYHA III) and an implantable cardioverter-defibrillator. Prospective 18-month randomized study
por: Smolis-Bąk, Edyta, et al.
Publicado: (2016)

Effect of vortioxetine on proinflammatory cytokine levels in patients with heart failure and comorbid depression
por: Sikora, A., et al.
Publicado: (2021)

Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA class
por: Santos-Lozano, Alejandro, et al.
Publicado: (2017)

Depression and health-related quality of life in critical COVID-19 survivors
por: Silva, J., et al.
Publicado: (2022)

Anxiety symptoms in critically ill COVID-19 survivors and its association with post-discharge health concerns
por: Silva, B., et al.
Publicado: (2022)

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure
por: Wohlford, George F., et al.
Publicado: (2021)

Associations of medicine use and ejection fraction with the coexistence of frailty and sarcopenia in a sample of heart failure outpatients: a cross-sectional study
por: Valdiviesso, Rui, et al.
Publicado: (2023)

Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

The power of multimodal antidepressants: decrease of soluble ST2 blood level in patients with depression and comorbid heart failure
por: Sikora, A. K., et al.
Publicado: (2023)

Post-discharge depressive symptoms and health-related quality of life of critical COVID-19 survivors
por: Martins, S., et al.
Publicado: (2021)

Transendocardial, autologous bone-marrow cell transplant in severe, chronic ischemic heart failure
por: Dohman, HF, et al.
Publicado: (2003)

Assessment of heart failure parameters by telemonitoring patients with an implantable cardioverter defibrillator
por: Fily, M, et al.
Publicado: (2022)

Performance of a multisensory implantable cardioverter-defibrillator algorithm for remote heart failure management: the RE-HEART registry
por: De Juan Baguda, J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0foqtampnd6q1jfhsearn72h7m